Real-world patient-level cost-effectiveness analysis of omalizumab in patients with severe allergic asthma treated in four major medical centers in Turkey


Tugay D., Top M., Aydın Ö., Bavbek S., Damadoğlu E., Erkekol F. Ö., ...More

JOURNAL OF MEDICAL ECONOMICS, vol.26, pp.1-10, 2023 (SCI-Expanded)